MATRIX PHARMACEUTICALS ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS (CVR number: 29625867) is a company from KØBENHAVN. The company reported a net sales of 1 mDKK in 2024, demonstrating a decline of -17.8 % compared to the previous year. The operating profit percentage was at 51.9 % (EBIT: 0.5 mDKK), while net earnings were 440 kDKK. The profitability of the company measured by Return on Assets (ROA) was 251.9 %, which can be considered excellent and Return on Equity (ROE) was 582.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 22.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. MATRIX PHARMACEUTICALS ApS's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 1 166.04 | 1 193.10 | 980.76 | ||
Gross profit | 849.19 | 843.00 | 1 166.04 | 1 193.10 | 509.37 |
EBIT | 849.19 | 843.00 | 1 166.04 | 1 193.10 | 509.37 |
Net earnings | 730.86 | 776.31 | 580.42 | 544.13 | 440.03 |
Shareholders equity total | -1 454.52 | - 678.21 | -80.42 | -44.13 | 59.97 |
Balance sheet total (assets) | 96.35 | 119.92 | 96.12 | 91.02 | 269.27 |
Net debt | 1 188.97 | 339.21 | 176.53 | 135.14 | 8.35 |
Profitability | |||||
EBIT-% | 100.0 % | 100.0 % | 51.9 % | ||
ROA | 43.5 % | 71.8 % | 239.3 % | 765.6 % | 251.9 % |
ROE | -190.9 % | 717.9 % | 537.3 % | 581.5 % | 582.8 % |
ROI | 60.1 % | 110.3 % | 452.2 % | 765.6 % | 251.9 % |
Economic value added (EVA) | 928.53 | 856.34 | 1 183.07 | 1 188.27 | 504.79 |
Solvency | |||||
Equity ratio | -93.8 % | -85.0 % | -45.6 % | -32.7 % | 22.3 % |
Gearing | -81.7 % | -50.0 % | -219.5 % | -306.3 % | 349.0 % |
Relative net indebtedness % | 15.1 % | 11.3 % | 0.9 % | ||
Liquidity | |||||
Quick ratio | 0.1 | 0.2 | 0.5 | 0.7 | 1.3 |
Current ratio | 0.1 | 0.2 | 0.5 | 0.7 | 1.3 |
Cash and cash equivalents | 200.95 | ||||
Capital use efficiency | |||||
Trade debtors turnover (days) | 30.1 | 27.8 | 25.4 | ||
Net working capital % | -6.9 % | -3.7 % | 6.1 % | ||
Credit risk | |||||
Credit rating | B | B | BB | B | BB |
Variable visualization
Roles
Companies in the same industry
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.